搜索
Portage Biotech Inc
PRTG添加自选
6.810USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
11.26M总市值
亏损市盈率 TTM
关于 Portage Biotech Inc 公司
Portage Biotech Inc. 是一家临床阶段的免疫肿瘤学公司。该公司致力于推进治疗方法，以改善癌症患者的长期治疗反应和生活质量。该公司利用技术与生物机制相结合，能够确定临床治疗方法和产品开发策略，从而加速这些药物通过转化渠道。该公司的产品组合由四个平台组成，主要项目包括不变的自然杀伤 T 细胞 (iNKT) 接合剂和一套针对腺苷途径的治疗方法。在这四个平台中，该公司有九个候选产品，其中五个处于临床前阶段，四个处于临床阶段。该公司的产品组合还包括小分子腺苷抑制剂，例如 PORT-6、PORT-7、PORT-8 和 PORT-9，它们代表针对腺苷途径。
Portage Biotech Inc简介
公司代码PRTG
公司名称Portage Biotech Inc
上市日期Oct 28, 2013
CEOMr. Alexander (Alex) Pickett
员工数量3
证券类型Ordinary Share
年结日Oct 28
公司地址Clarence Thomas Building
城市TORTOLA
上市交易所NASDAQ Capital Market Consolidated
国家Virgin Islands; British
邮编VG1110
电话4167377600
网址https://portagebiotech.com/
公司代码PRTG
上市日期Oct 28, 2013
CEOMr. Alexander (Alex) Pickett
Portage Biotech Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Gregory Hugh (Greg) Bailey, M.D.
Dr. Gregory Hugh (Greg) Bailey, M.D.
Lead Independent Director
Lead Independent Director
467.80K
-0.00%
Mr. James (Jim) Mellon
Mr. James (Jim) Mellon
Independent Director
Independent Director
239.54K
-0.01%
Mr. Steven Michael (Steve) Mintz
Mr. Steven Michael (Steve) Mintz
Independent Director
Independent Director
7.00K
+2.19%
Mr. Robert Kramer, Ph.D.
Mr. Robert Kramer, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.04K
-0.56%
Mr. Alexander (Alex) Pickett
Mr. Alexander (Alex) Pickett
Chief Executive Officer, Director
Chief Executive Officer, Director
38.00
--
Ms. Andrea Park
Ms. Andrea Park
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Ian B. Walters, M.D.
Dr. Ian B. Walters, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Andrew D. Hudders
Mr. Andrew D. Hudders
Investor Relations
Investor Relations
--
--
Dr. Jean-Christophe Renondin, M.D.
Dr. Jean-Christophe Renondin, M.D.
Independent Director
Independent Director
--
--
Mr. Justin Fairchild
Mr. Justin Fairchild
Vice President - Development
Vice President - Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Gregory Hugh (Greg) Bailey, M.D.
Dr. Gregory Hugh (Greg) Bailey, M.D.
Lead Independent Director
Lead Independent Director
467.80K
-0.00%
Mr. James (Jim) Mellon
Mr. James (Jim) Mellon
Independent Director
Independent Director
239.54K
-0.01%
Mr. Steven Michael (Steve) Mintz
Mr. Steven Michael (Steve) Mintz
Independent Director
Independent Director
7.00K
+2.19%
Mr. Robert Kramer, Ph.D.
Mr. Robert Kramer, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.04K
-0.56%
Mr. Alexander (Alex) Pickett
Mr. Alexander (Alex) Pickett
Chief Executive Officer, Director
Chief Executive Officer, Director
38.00
--
Ms. Andrea Park
Ms. Andrea Park
Chief Financial Officer
Chief Financial Officer
--
--
常见问题
Portage Biotech Inc的前五大股东是谁？
Portage Biotech Inc 的前五大股东如下：Dr. Gregory Hugh (Greg) Bailey, M.D.
有多少机构持有Portage Biotech Inc(PRTG)的股份？
截至2026Q1，共有48家机构持有Portage Biotech Inc的股份，合计持有的股份价值约为928.66K，占公司总股份的3.96%。与2025Q4相比，机构持股有所增加，增幅为644865.00。